Loading…

The epidemiology of hepatitis B virus infection in Korea

The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatiti...

Full description

Saved in:
Bibliographic Details
Published in:The Korean journal of internal medicine 2019, 34(5), , pp.945-953
Main Authors: Yim, Sun Young, Kim, Ji Hoon
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93
cites cdi_FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93
container_end_page 953
container_issue 5
container_start_page 945
container_title The Korean journal of internal medicine
container_volume 34
creator Yim, Sun Young
Kim, Ji Hoon
description The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatitis B e-antigen seropositivity, and viral load. It is important to identify these risk factors and start antiviral treatment at an appropriate time according to current guidelines. The most crucial step in reducing HBV infection is prevention in infancy or early childhood, as infection at an early stage may lead to chronicity. South Korea was formerly an HBV-endemic area, but the epidemiology of HBV infection was changed by the introduction of vaccination in 1983 and nationwide immunization in 1995. The government and the private sector made efforts to reduce the prevalence of HBV infection, and Korea is on target to meet the World Health Organization goal of eliminating viral hepatitis by 2030. To eliminate hepatitis worldwide, the costs of antiviral treatment to prevent perinatal HBV transmission in pregnant women with high viremia should be covered by a national program, and strategies to reduce the prevalence of HBV infection in immigrant populations are needed.
doi_str_mv 10.3904/kjim.2019.007
format article
fullrecord <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_5976352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fbb3df2411334b0881e04f92874ebd89</doaj_id><sourcerecordid>2199194304</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93</originalsourceid><addsrcrecordid>eNpVkU1vEzEURS0EoqGwZItmCYsJzx_x2BukUgGNqISEwtryeJ4TJzPjYE8q9d_jJKVqV7bs-8670iHkPYU51yA-77ZhmDOgeg7QvCAzBrCopRTqJZlRxmTNOfAL8ibnLYBsQPHX5IKDplqCmhG12mCF-9DhEGIf1_dV9NUG93YKU8jV1-oupEOuwujRTSGO5Vb9jAntW_LK2z7ju4fzkvz5_m11fVPf_vqxvL66rZ1QzVRrpjqtHGtkaxl1slToQEuNlFvReNshKKGFXzjpdePAo3VCgvNlpnVW80vy6cwdkzc7F0y04XSuo9klc_V7tTQL3Ui-YCW7PGe7aLdmn8Jg0_1p4PQQ09rYNAXXo_FtyzvPBKWcixaUogjCl7aNwLZTx71fzqz9oR2wczhOyfbPoM9_xrApne6MbGiBNAXw8QGQ4t8D5skMITvseztiPGTDqC4SBAdRovU56lLMOaF_XEPBHC2bo2VztGyK5ZL_8LTbY_q_Vv4Pj7OiqA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2199194304</pqid></control><display><type>article</type><title>The epidemiology of hepatitis B virus infection in Korea</title><source>PubMed Central (Open Access)</source><creator>Yim, Sun Young ; Kim, Ji Hoon</creator><creatorcontrib>Yim, Sun Young ; Kim, Ji Hoon</creatorcontrib><description>The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatitis B e-antigen seropositivity, and viral load. It is important to identify these risk factors and start antiviral treatment at an appropriate time according to current guidelines. The most crucial step in reducing HBV infection is prevention in infancy or early childhood, as infection at an early stage may lead to chronicity. South Korea was formerly an HBV-endemic area, but the epidemiology of HBV infection was changed by the introduction of vaccination in 1983 and nationwide immunization in 1995. The government and the private sector made efforts to reduce the prevalence of HBV infection, and Korea is on target to meet the World Health Organization goal of eliminating viral hepatitis by 2030. To eliminate hepatitis worldwide, the costs of antiviral treatment to prevent perinatal HBV transmission in pregnant women with high viremia should be covered by a national program, and strategies to reduce the prevalence of HBV infection in immigrant populations are needed.</description><identifier>ISSN: 1226-3303</identifier><identifier>EISSN: 2005-6648</identifier><identifier>DOI: 10.3904/kjim.2019.007</identifier><identifier>PMID: 30919608</identifier><language>eng</language><publisher>Korea (South): The Korean Association of Internal Medicine</publisher><subject>Adolescent ; Adult ; Aged ; Antiviral Agents - therapeutic use ; Child ; Emigration and Immigration ; epidemiology ; Female ; Hepatitis B Vaccines - therapeutic use ; hepatitis b, chronic ; Hepatitis B, Chronic - epidemiology ; Hepatitis B, Chronic - prevention &amp; control ; Hepatitis B, Chronic - transmission ; Humans ; Incidence ; Infectious Disease Transmission, Vertical ; Male ; Middle Aged ; Pregnancy ; Prevalence ; Prognosis ; Republic of Korea - epidemiology ; Review ; Risk Factors ; Time Factors ; vaccination ; Young Adult ; 내과학</subject><ispartof>The Korean Journal of Internal Medicine, 2019, 34(5), , pp.945-953</ispartof><rights>Copyright © 2019 The Korean Association of Internal Medicine 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93</citedby><cites>FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718747/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718747/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30919608$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002494298$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Yim, Sun Young</creatorcontrib><creatorcontrib>Kim, Ji Hoon</creatorcontrib><title>The epidemiology of hepatitis B virus infection in Korea</title><title>The Korean journal of internal medicine</title><addtitle>Korean J Intern Med</addtitle><description>The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatitis B e-antigen seropositivity, and viral load. It is important to identify these risk factors and start antiviral treatment at an appropriate time according to current guidelines. The most crucial step in reducing HBV infection is prevention in infancy or early childhood, as infection at an early stage may lead to chronicity. South Korea was formerly an HBV-endemic area, but the epidemiology of HBV infection was changed by the introduction of vaccination in 1983 and nationwide immunization in 1995. The government and the private sector made efforts to reduce the prevalence of HBV infection, and Korea is on target to meet the World Health Organization goal of eliminating viral hepatitis by 2030. To eliminate hepatitis worldwide, the costs of antiviral treatment to prevent perinatal HBV transmission in pregnant women with high viremia should be covered by a national program, and strategies to reduce the prevalence of HBV infection in immigrant populations are needed.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Child</subject><subject>Emigration and Immigration</subject><subject>epidemiology</subject><subject>Female</subject><subject>Hepatitis B Vaccines - therapeutic use</subject><subject>hepatitis b, chronic</subject><subject>Hepatitis B, Chronic - epidemiology</subject><subject>Hepatitis B, Chronic - prevention &amp; control</subject><subject>Hepatitis B, Chronic - transmission</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infectious Disease Transmission, Vertical</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pregnancy</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Republic of Korea - epidemiology</subject><subject>Review</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>vaccination</subject><subject>Young Adult</subject><subject>내과학</subject><issn>1226-3303</issn><issn>2005-6648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1vEzEURS0EoqGwZItmCYsJzx_x2BukUgGNqISEwtryeJ4TJzPjYE8q9d_jJKVqV7bs-8670iHkPYU51yA-77ZhmDOgeg7QvCAzBrCopRTqJZlRxmTNOfAL8ibnLYBsQPHX5IKDplqCmhG12mCF-9DhEGIf1_dV9NUG93YKU8jV1-oupEOuwujRTSGO5Vb9jAntW_LK2z7ju4fzkvz5_m11fVPf_vqxvL66rZ1QzVRrpjqtHGtkaxl1slToQEuNlFvReNshKKGFXzjpdePAo3VCgvNlpnVW80vy6cwdkzc7F0y04XSuo9klc_V7tTQL3Ui-YCW7PGe7aLdmn8Jg0_1p4PQQ09rYNAXXo_FtyzvPBKWcixaUogjCl7aNwLZTx71fzqz9oR2wczhOyfbPoM9_xrApne6MbGiBNAXw8QGQ4t8D5skMITvseztiPGTDqC4SBAdRovU56lLMOaF_XEPBHC2bo2VztGyK5ZL_8LTbY_q_Vv4Pj7OiqA</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Yim, Sun Young</creator><creator>Kim, Ji Hoon</creator><general>The Korean Association of Internal Medicine</general><general>대한내과학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><scope>ACYCR</scope></search><sort><creationdate>20190901</creationdate><title>The epidemiology of hepatitis B virus infection in Korea</title><author>Yim, Sun Young ; Kim, Ji Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Child</topic><topic>Emigration and Immigration</topic><topic>epidemiology</topic><topic>Female</topic><topic>Hepatitis B Vaccines - therapeutic use</topic><topic>hepatitis b, chronic</topic><topic>Hepatitis B, Chronic - epidemiology</topic><topic>Hepatitis B, Chronic - prevention &amp; control</topic><topic>Hepatitis B, Chronic - transmission</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infectious Disease Transmission, Vertical</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pregnancy</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Republic of Korea - epidemiology</topic><topic>Review</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>vaccination</topic><topic>Young Adult</topic><topic>내과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yim, Sun Young</creatorcontrib><creatorcontrib>Kim, Ji Hoon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (Open Access)</collection><collection>Korean Citation Index</collection><jtitle>The Korean journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yim, Sun Young</au><au>Kim, Ji Hoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The epidemiology of hepatitis B virus infection in Korea</atitle><jtitle>The Korean journal of internal medicine</jtitle><addtitle>Korean J Intern Med</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>34</volume><issue>5</issue><spage>945</spage><epage>953</epage><pages>945-953</pages><issn>1226-3303</issn><eissn>2005-6648</eissn><abstract>The global burden of hepatitis B virus (HBV) infection is profound, and represents a public health threat as chronic infection can lead to liver cirrhosis, hepatocellular carcinoma, and death. The risk factors for chronic hepatitis B-related liver disease differ according to HBV endemicity, hepatitis B e-antigen seropositivity, and viral load. It is important to identify these risk factors and start antiviral treatment at an appropriate time according to current guidelines. The most crucial step in reducing HBV infection is prevention in infancy or early childhood, as infection at an early stage may lead to chronicity. South Korea was formerly an HBV-endemic area, but the epidemiology of HBV infection was changed by the introduction of vaccination in 1983 and nationwide immunization in 1995. The government and the private sector made efforts to reduce the prevalence of HBV infection, and Korea is on target to meet the World Health Organization goal of eliminating viral hepatitis by 2030. To eliminate hepatitis worldwide, the costs of antiviral treatment to prevent perinatal HBV transmission in pregnant women with high viremia should be covered by a national program, and strategies to reduce the prevalence of HBV infection in immigrant populations are needed.</abstract><cop>Korea (South)</cop><pub>The Korean Association of Internal Medicine</pub><pmid>30919608</pmid><doi>10.3904/kjim.2019.007</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1226-3303
ispartof The Korean Journal of Internal Medicine, 2019, 34(5), , pp.945-953
issn 1226-3303
2005-6648
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_5976352
source PubMed Central (Open Access)
subjects Adolescent
Adult
Aged
Antiviral Agents - therapeutic use
Child
Emigration and Immigration
epidemiology
Female
Hepatitis B Vaccines - therapeutic use
hepatitis b, chronic
Hepatitis B, Chronic - epidemiology
Hepatitis B, Chronic - prevention & control
Hepatitis B, Chronic - transmission
Humans
Incidence
Infectious Disease Transmission, Vertical
Male
Middle Aged
Pregnancy
Prevalence
Prognosis
Republic of Korea - epidemiology
Review
Risk Factors
Time Factors
vaccination
Young Adult
내과학
title The epidemiology of hepatitis B virus infection in Korea
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A35%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20epidemiology%20of%20hepatitis%20B%20virus%20infection%20in%20Korea&rft.jtitle=The%20Korean%20journal%20of%20internal%20medicine&rft.au=Yim,%20Sun%20Young&rft.date=2019-09-01&rft.volume=34&rft.issue=5&rft.spage=945&rft.epage=953&rft.pages=945-953&rft.issn=1226-3303&rft.eissn=2005-6648&rft_id=info:doi/10.3904/kjim.2019.007&rft_dat=%3Cproquest_nrf_k%3E2199194304%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c487t-928d98c276ba21c6067d0969e13a47fade08494f5c6f97c0feac460cf8c2bca93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2199194304&rft_id=info:pmid/30919608&rfr_iscdi=true